Name | ethyl 2-((2-chlorophenyl)(hydroxy)methyl)acrylate |
---|---|
Synonyms |
2-[hydroxy(2-chlorophenyl)methyl]acrylic acid ethyl ester
2-[(2-Chloro-phenyl)-hydroxy-methyl]-acrylic acid ethyl ester |
Description | INF4E is a potent NLRP3 inflammasome inhibitor. INF4E inhibits caspase-1 and NLRP3 ATPase activities. INF4E shows protection against the IR-induced myocardial injury and dysfunction[1][2]. |
---|---|
Related Catalog | |
In Vitro | INF4E (compound 9) preventes both ATP- and nigericin-triggered pyroptosis of human THP-1 cells in a time- and concentration-dependent mannersup>[3]. |
In Vivo | INF4E significantly reduces the in infarct size and lactate dehydrogenase release and improvement in postischemic left ventricular pressure[1]. INF4E attenuates the formation of NLRP3 inflammasome complex was induced by myocardial IR (ischemia/reperfusion) in a time-dependent way[1]. |
References |
Molecular Formula | C12H13ClO3 |
---|---|
Molecular Weight | 240.68300 |
Exact Mass | 240.05500 |
PSA | 46.53000 |
LogP | 2.49270 |
Storage condition | -20°C |